Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: International Conference for Healthcare and Medical Students 2012

Open Access Poster presentation

Microvolt T-wave alternation in left ventricular hypertrophy patients

Goar Arutyunyan*, DA Tsaregorodtsev and IR Bukiya

Author Affiliations

I.M. Sechenov First Moscow Medical State University, Moscow, Russia

For all author emails, please log on.

BMC Proceedings 2013, 7(Suppl 1):P8  doi:10.1186/1753-6561-7-S1-P8

The electronic version of this article is the complete one and can be found online at:

Published:30 January 2013

© 2013 Arutyunyan et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Sudden cardiac death (SCD) is responsible for 11% of all deaths and 50% of all cardiovascular deaths. Hypertrophic cardiomyopathy (HCM) is the most common cause of SCD among the young patients. SCD is often the first manifestation of the disease. There are 5 major risk factors for SCD in patients with HCM. However, no single risk factor can be used as a screening test in assessment of SCD. Nowadays new non-invasive risk factors, such as T-wave alternation (TWA), are being studied. They may provide important information on the patient’s susceptibility to life threatening arrhythmias.


The study involved 33 hypertensive heart disease (HHD) patients and 22 HCM patients. All patients underwent echocardiography test (ECHO) and 24h Holter monitoring with mTWA evaluation using the modified moving average method. The evaluation involved maximum mTWA figures in 24h (mTWA max), mTWA figures at the heart rate of 100/min (mTWA 100) and at 5:00 am (mTWA 5:00).


The common group demonstrated a weak direct correlation between the thickness of ventricular septum (IVSth) and mTWA max, as well as a weak reverse correlation between the left ventricular posterior wall thickness (LVPWth) and mTWA 100. These correlation were revealed primarily in HHD patients who demonstrated correlation between mTWA max and IVSth, between mTWA 5:00 and IVSth, LVPWth, as well as between mTWA 100 and LVPWth. The HCM patients did not demonstrate correlation between mTWA and the thickness of left ventricular wall. The patients with non-obstructive HCM (n=15) demonstrated significantly higher mTWA 100 in comparison to the patients with obstructive HCM (n=5). The presence of higher SCD risk factors in the HCM patients (n=6) did not influenced mTWA figures. The mTWA figures in the HHD and HCM patients differed insignificantly, with the only exception of higher mTWA 5:00 in the HHD in comparison to the HCM group.


mTWA figures correlate with the degree of left ventricular hypertrophy, however the revealed correlations are weak. The causes of lower MTWA 100 in patients with more intensive hypertrophy (reverse correlation) as well as in patients with obstructive HCM in comparison with non-obstructive HCM call for additional studies.